US Patent 11510981 Nanoparticle compositions and methods for immunotherapy
Patent 11510981 was granted and assigned to NexImmune on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 28 Mar, 2023
Golden AI
Infobox
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115109810
Date of Patent
November 29, 2022
0Patent Application Number
168221670
Date Filed
March 18, 2020
0Patent Primary Examiner
Edits on 30 Nov, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+394 characters)
US Patent 11510981 Nanoparticle compositions and methods for immunotherapy
Article
The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes for presentation of an antigen (e.g., a tumor antigen) and/or a T cell co-stimulatory molecule.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115109810
Date of Patent
November 29, 2022
0Patent Application Number
168221670
Date Filed
March 18, 2020
0Patent Primary Examiner
Find more entities like US Patent 11510981 Nanoparticle compositions and methods for immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
